A detailed history of Swiss National Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Swiss National Bank holds 2,397,890 shares of LLY stock, worth $1.87 Billion. This represents 1.41% of its overall portfolio holdings.

Number of Shares
2,397,890
Previous 2,392,790 0.21%
Holding current value
$1.87 Billion
Previous $2.17 Billion 1.94%
% of portfolio
1.41%
Previous 1.52%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $3.94 Million - $4.9 Million
5,100 Added 0.21%
2,397,890 $2.12 Billion
Q2 2024

Aug 08, 2024

SELL
$724.87 - $909.04 $17.2 Million - $21.5 Million
-23,700 Reduced 0.98%
2,392,790 $2.17 Billion
Q1 2024

May 07, 2024

SELL
$592.2 - $792.28 $63.2 Million - $84.6 Million
-106,800 Reduced 4.23%
2,416,490 $1.88 Billion
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $37.8 Million - $44.6 Million
-72,000 Reduced 2.77%
2,523,290 $1.47 Billion
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $140 Million - $193 Million
-322,000 Reduced 11.04%
2,595,290 $1.39 Billion
Q2 2023

Aug 09, 2023

SELL
$350.74 - $468.98 $101 Million - $135 Million
-288,000 Reduced 8.99%
2,917,290 $1.37 Billion
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $24 Million - $28.2 Million
-77,200 Reduced 2.35%
3,205,290 $1.1 Billion
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $70 Million - $81.5 Million
-217,558 Reduced 6.22%
3,282,490 $1.2 Billion
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $3.38 Million - $3.85 Million
-11,400 Reduced 0.32%
3,500,048 $1.13 Billion
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $2.87 Million - $3.37 Million
-10,300 Reduced 0.29%
3,511,448 $1.14 Billion
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $101 Million - $126 Million
431,200 Added 13.95%
3,521,748 $1.01 Billion
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $29.8 Million - $37 Million
-132,600 Reduced 4.11%
3,090,548 $854 Million
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $21.9 Million - $26.9 Million
-98,800 Reduced 2.97%
3,223,148 $745 Million
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $98.2 Million - $127 Million
-543,650 Reduced 14.06%
3,321,948 $762 Million
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $10.9 Million - $14.1 Million
66,100 Added 1.74%
3,865,598 $722 Million
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $11.7 Million - $15.5 Million
-90,000 Reduced 2.31%
3,799,498 $642 Million
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $7.52 Million - $8.69 Million
-51,400 Reduced 1.3%
3,889,498 $576 Million
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $2.86 Million - $3.45 Million
21,000 Added 0.54%
3,940,898 $647 Million
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $81.1 Million - $100 Million
681,300 Added 21.04%
3,919,898 $544 Million
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $14.7 Million - $18.2 Million
-137,400 Reduced 4.07%
3,238,598 $426 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $5.93 Million - $6.45 Million
-55,558 Reduced 1.62%
3,375,998 $378 Million
Q2 2019

Aug 02, 2019

SELL
$110.79 - $129.32 $8.61 Million - $10 Million
-77,700 Reduced 2.21%
3,431,556 $380 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $20.5 Million - $24.1 Million
-184,087 Reduced 4.98%
3,509,256 $455 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $169,440 - $189,824
1,600 Added 0.04%
3,693,343 $427 Million
Q3 2018

Nov 08, 2018

SELL
$85.86 - $107.31 $13.7 Million - $17.1 Million
-159,400 Reduced 4.14%
3,691,743 $396 Million
Q2 2018

Aug 09, 2018

BUY
$75.7 - $86.88 $6.42 Million - $7.37 Million
84,800 Added 2.25%
3,851,143 $329 Million
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $30.2 Million - $35.7 Million
-407,400 Reduced 9.76%
3,766,343 $291 Million
Q4 2017

Feb 07, 2018

BUY
$81.94 - $87.89 $1.34 Million - $1.43 Million
16,300 Added 0.39%
4,173,743 $353 Million
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $320 Million - $356 Million
4,157,443
4,157,443 $356 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.